Prelude Therapeutics (PRLD) Depreciation & Amortization (CF) (2019 - 2026)
Prelude Therapeutics' Depreciation & Amortization (CF) came in at $353,000 for Q2 2026, down 18.5% from $433,000 a year earlier and down 9.7% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Prelude Therapeutics reported Depreciation & Amortization (CF) of $1.59 million, down 9.9% year-over-year; for FY2025, it was $1.71 million, down 3.4% from FY2024.
- Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 25.8% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $1.77 million in FY2024 (+51.6%), $1.17 million in FY2023 (-11.7%), $1.32 million in FY2022 (+44.7%) and $915,000 in FY2021 (+68.8%).
- The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q4 2023.
- Year-over-year, Depreciation & Amortization (CF) has declined for three consecutive quarters, with growth averaging 6.6% over the last eight quarters.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2021 (growth of 118.0%), and the weakest in Q2 2026 (a decline of 18.5%).
- Business Quant data shows PRLD's Depreciation & Amortization (CF) at $391,000 (Q1 2026), $418,000 (Q4 2025) and $425,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Prelude Therapeutics | 366.99 Mn | -230.31 Mn | - | 353,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 353,000.00 |
| Mar 31, 2026 | 391,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 425,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | 489,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 452,000.00 |
| Mar 31, 2024 | 426,000.00 |
| Dec 31, 2023 | 331,000.00 |
| Sep 30, 2023 | 279,000.00 |
| Jun 30, 2023 | 281,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | 362,000.00 |
| Sep 30, 2022 | 337,000.00 |
| Jun 30, 2022 | 318,000.00 |
| Mar 31, 2022 | 307,000.00 |
| Dec 31, 2021 | 290,000.00 |
| Sep 30, 2021 | 266,000.00 |
API Access
Prelude Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();